Literature DB >> 1081410

Classification of lymphocytes in nasopharyngeal carcinoma (NPC) biopsies.

M Jondal, G Klein.   

Abstract

Seven biopsies taken from nasopharyngeal carcinoma tissues were analyzed with regard to infiltrating B or T lymphocytes. The vast majority of these cells had the capacity to form SRBC rosettes (mean 87%) and were thus classified as T cells. Varying proportions of these were blast-transformed suggesting that they represented a host response against the tumor.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1081410

Source DB:  PubMed          Journal:  Biomedicine        ISSN: 0300-0893


  6 in total

1.  S-100 protein positive cells in nasopharyngeal carcinoma (NPC): absence of prognostic significance. A clinicopathological and immunohistochemical study of 40 cases.

Authors:  F J Vera-Sempere; C Micheau; A Llombart-Bosch
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

2.  Detection of S-100 labelled cells in nasopharyngeal carcinoma.

Authors:  L Lauriola; F Michetti; S Sentinelli; D Cocchia
Journal:  J Clin Pathol       Date:  1984-11       Impact factor: 3.411

3.  An immunohistologic study of the distribution and status of activation of head and neck tumor infiltrating leukocytes.

Authors:  K Böheim; H Denz; C Böheim; H Glassl; H Huber
Journal:  Arch Otorhinolaryngol       Date:  1987

4.  Immunohistological characteristics of the infiltrating lymphoid cells and expression of HLA class I and II antigens in nasopharyngeal carcinoma.

Authors:  F M Lai; P N Cheng; S Y Tsao; K N Lai
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

5.  The tumor microenvironment: the making of a paradigm.

Authors:  Isaac P Witz
Journal:  Cancer Microenviron       Date:  2009-08-23

6.  Cytogenetics of malignant epithelial cells and lymphoblastoid cell lines from nasopharyngeal carcinoma.

Authors:  S Finerty; J E Jarvis; M A Epstein; P A Trumper; G Ball; B C Giovanella
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.